Get the Stockscreener App
7.38
1.60%
-0.12
After Hours:
7.35
-0.03
-0.41%
Fennec Pharmaceuticals Inc stock is traded at $7.38, with a volume of 53,026.
It is down -1.60% in the last 24 hours and down -2.25% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$7.50
Open:
$7.48
24h Volume:
53,026
Relative Volume:
0.37
Market Cap:
$252.05M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-12.10
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
-4.90%
1M Performance:
-2.25%
6M Performance:
-16.14%
1Y Performance:
+21.38%
1-Day Range:
$7.35
$7.60
1-Week Range:
$7.35
$7.84
52-Week Range:
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.38 | 256.15M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Positive Signs As Multiple Insiders Buy Fennec Pharmaceuticals Stock - Yahoo Finance
(FRX) Pivots Trading Plans and Risk Controls (FRX:CA) - Stock Traders Daily
Aug Final Week: Is Fennec Pharmaceuticals Inc RV41 stock undervalued by metricsTrade Volume Report & Weekly High Return Stock Forecasts - moha.gov.vn
Is Fennec Pharmaceuticals Inc RV41 a good long term investmentStock Split Announcements & High Profit Portfolio Growth - earlytimes.in
Fennec Pharmaceuticals Inc (TSX:FRX) Slipped Under Its Trend Key Levels Matter - Kalkine Media
(FRX) On The My Stocks Page (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving Average – Here’s Why - Defense World
Aug Opening: Can Fennec Pharmaceuticals Inc RV41 stock stage a strong rebound this quarterPortfolio Gains Summary & Safe Swing Trade Setups - moha.gov.vn
Adherex Technologies (NASDAQ:FENC) Major Shareholder Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Stock - Defense World
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Adherex Technologies (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals Says Southpoint Capital Sold 1 Million Shares - marketscreener.com
Southpoint trims stake in Fennec Pharmaceuticals to 8% - MSN
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - The Manila Times
Southpoint Capital Advisors controls 2.7 million common shares, 8% of outstanding common shares of Fennec - marketscreener.com
Southpoint Trims Stake in Fennec Pharmaceuticals to 8% - TipRanks
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewswire Inc.
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC) - Seeking Alpha
Is Fennec Pharmaceuticals Inc. stock cheap at current valuation2025 Geopolitical Influence & Reliable Intraday Trade Plans - Улправда
Portfolio Update: How Fennec Pharmaceuticals Inc. stock trades before earningsWatch List & Risk Managed Trade Strategies - Улправда
How Fennec Pharmaceuticals Inc. stock performs after earningsOptions Play & Advanced Swing Trade Entry Alerts - Улправда
Is Fennec Pharmaceuticals Inc. stock recession proofAnalyst Upgrade & Long-Term Safe Return Strategies - Улправда
Can Fennec Pharmaceuticals Inc. (RV41) stock hold up in economic slowdownIPO Watch & Comprehensive Market Scan Insights - Улправда
(FRX) Equity Trading Insights (FRX:CA) - Stock Traders Daily
(FENC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Fennec Pharmaceuticals (TSX:FRX) Operate Today In Precision Oncology - Kalkine Media
(FRX) Equity Market Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals Earnings Notes - Trefis
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,061,087.30 in Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,799,524.00 in Stock - MarketBeat
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
Fennec Pharmaceuticals Announces Private Offering to Bolster Financial Position - MSN
(FRX) Risk-Controlled Trading Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals supports new trial for hearing loss prevention in cancer treatment - MSN
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Pfizer (PFE) - The Globe and Mail
How To Trade (FRX) (FRX:CA) - Stock Traders Daily
Stocks in play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Announces Trial Investigating Pedmark to Prevent Hearing Loss in Adult Men - marketscreener.com
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Tumors - marketscreener.com
Fennec Pharmaceuticals Supports New Trial for Hearing Loss Prevention in Cancer Treatment - TipRanks
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors - marketscreener.com
Fennec Pharma announces City of Hope PEDMARK trial in metastatic testicular tumors | FENC Stock News - Stock Titan
Trend Recap: Will Fennec Pharmaceuticals Inc stock benefit from automationQuarterly Investment Review & Free High Return Stock Watch Alerts - moha.gov.vn
Sentiment Recap: Is Fennec Pharmaceuticals Inc stock resilient to inflation2025 Sector Review & Reliable Intraday Trade Plans - moha.gov.vn
(FRX) Trading Performance and Risk Management (FRX:CA) - Stock Traders Daily
Retail Surge: Will Fennec Pharmaceuticals Inc RV41 stock hit Wall Street targetsMarket Volume Report & Real-Time Sentiment Analysis - BỘ NỘI VỤ
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):